Citation Impact

Citing Papers

Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy
2018
Salvage endoscopic nasopharyngectomy and intensity‐modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma
2014
Progress report of a randomized trial comparing long‐term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China
2013
Bone grafts and biomaterials substitutes for bone defect repair: A review
2017 Standout
Breast cancer
2019 Standout
Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
2013
The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy
2014
Bone regeneration: current concepts and future directions
2011 Standout
Head and neck squamous cell carcinoma
2020 Standout
Nasopharyngeal carcinoma
2005 Standout
Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
2008
A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma
2013
Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid
2014
Large-scale gene function analysis with the PANTHER classification system
2013 Standout
Breast cancer
2016 Standout
Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma
2016
Long‐term survival analysis of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA levels
2012
Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma
2018
The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase iii randomized trials
2010
HPV Detection Methods in Head and Neck Cancer
2012
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Cushing's syndrome
2015 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Head and neck cancer
2008 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma
2010
Nasopharyngeal carcinoma
2019 Standout
Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer
2017
A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
2014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Long-Term Prognostic Effects of Plasma Epstein-Barr Virus DNA by Minor Groove Binder-Probe Real-Time Quantitative PCR on Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemoradiotherapy
2007
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Body Image of Women with Breast Cancer After Mastectomy: A Qualitative Research
2016 Standout
Nasopharyngeal carcinoma
2015 Standout
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy
2012
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
2018
The battle against nasopharyngeal cancer
2012
Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1β in human pancreatic cancer cells: Role of JNK
2012
Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies
2014
Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy
2010
Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era
2014
Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma
2013
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Comparison of Long-Term Survival and Toxicity of Cisplatin Delivered Weekly versus Every Three Weeks Concurrently with Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma
2014
Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
2014
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling
2018
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma
2014
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system
2015
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
2011
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients
2016
Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II–Induced Kidney Fibrosis
2015
Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer
2003
The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis
2014
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
2013
Contribution of Organofluorine Compounds to Pharmaceuticals
2020 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
2013
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Spontaneous remission of residual post‐therapy plasma Epstein–Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large‐scale, big‐data intelligence platform‐based analysis
2018
Prognostic Analysis of Adjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma
2013
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy
2017
Salvage surgery for nasopharyngeal cancer
2015
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Thermodynamic Consequences of Mutations in Vernier Zone Residues of a Humanized Anti-human Epidermal Growth Factor Receptor Murine Antibody, 528
2007
The role of apoptosis in radiation oncology
2009
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Platelet-Rich Plasma
2009 Standout
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
2015
Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma
2014
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Fluorine in medicinal chemistry: A review of anti-cancer agents
2006
The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery
2009
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
2017
Long‐term outcomes after reirradiation in nasopharyngeal carcinoma with intensity‐modulated radiotherapy: A meta‐analysis
2017
Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments
2008 Standout
Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials
2010

Works of T.K. Yau being referenced

Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
2010
Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control
2004
Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group
2005
Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma
2006
Clinical Outcome of Breast Conservation Therapy for Breast Cancer in Hong Kong: Prognostic Impact of Ipsilateral Breast Tumor Recurrence and 2005 St. Gallen Risk Categories
2007
A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma
2011
A Comparison Study of Different PCR Assays in Measuring Circulating Plasma Epstein-Barr Virus DNA Levels in Patients with Nasopharyngeal Carcinoma
2005
Nasopharyngeal carcinoma in situ
1998
Delayed presentation of symptomatic breast cancers in Hong Kong: experience in a public cancer centre.
2010
Rankless by CCL
2026